Clinical Trial: A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Relapsed or Refractory Multiple Myeloma
Study Type: INTERVENTIONAL
Official Title: A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multipl
Brief Summary:
The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd.
Read more